A recent study suggests that individuals who discontinue popular slimming jabs like Wegovy and Mounjaro tend to recover lost weight much more quickly than those who end traditional lifestyle plans.
Findings released in a prominent medical journal demonstrates that while obese individuals often shed a large proportion of their total mass while using the jabs, the mass is regained at an average rate of 0.8 kg per month upon discontinuation.
"Users buying these drugs must be aware of the danger of rapid weight regain when the medication concludes," stated lead investigator Dr. Susan Jebb.
Such speed of regain implies a return to pre-treatment mass within about a year and a half.
Analyzing Approaches
The analysis, which looked at dozens of trials involving thousands of participants, contrasted the effects of the injectable medications with other pills.
Researchers note that individuals who lose weight through diet and exercise usually experience a less rapid creep back—around 100 grams monthly—after stopping.
Explaining the Fast Rebound
Nutrition scientists believe the mode of action of the drugs explains the heightened rebound.
The injections imitate a body's own chemical called GLP-1, which helps regulate hunger.
"Sustained high doses of GLP-1 levels far above than normal may cause the body to generate a reduced amount of its own natural hormone, and may also lessen responsiveness to its effects," explained Dr. Adam Collins, a nutrition expert.
"Stopping of this GLP-1 'fix' leads to hunger is unsuppressed, making excessive eating far more likely."
A Lifelong Disease?
Medical guidelines advise the injections for individuals with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
Professionals say that, considering the likelihood of weight regain, the therapy is often long-term.
This perspective is reinforced by pharmaceutical companies, who say that the results "highlight the long-term nature of obesity," comparing it to managing diseases like diabetes.
Patient Testimonies
People who have discontinued the jabs report a intense return of hunger.
"It felt as if a switch activating and you're instantly extremely hungry," described one woman.
This challenge is exacerbated if individuals have not developed permanent dietary or behavioural modifications during treatment.
Growing Use
Figures suggest that millions of people in the UK have tried these injections in the past year, with desire remaining high.
- Use is more common among females than males.
- The 40s and 50s demographic shows the highest usage rates.
- Many obtain the medications through private prescriptions rather than public health services.
In conclusion, clinicians emphasize that while GLP-1 drugs are potent agents for weight loss, they are not a permanent solution and maintained weight loss relies on integrated lifestyle changes.
